nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.02.2015 | Rapid Communication

Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference

verfasst von: V. Fadda, D. Maratea, S. Trippoli, A. Messori

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

This study was aimed at comparing the safety of bisphosphonates in women with osteoporosis by application of equivalence testing.

Methods

Gastrointestinal and renal side effects were evaluated based on information published in randomized controlled trials.

Results

The data on gastrointestinal side effects (47 trials) indicated that alendronate, risedronate etidronate, and zolendronate have similar rates of the adverse effects; application of Bayesian network meta-analysis showed that equivalence was demonstrated according to margins around ±10 %. The data on renal safety were more sparse and suffered from the use of different outcome measures; hence, a single trial could be evaluated. This trial showed a similar effect of alendronate and risedronate on renal function at 12 months; equivalence was based on differences between the two agents in renal function with margins of less than ±10.4 ml/min.

Conclusion

Our study provided quantitative information to determine to what extent bisphosphonates can be considered equivalent in terms of gastrointestinal and renal side effects.

Mascha EJ (2010) Equivalence and noninferiority testing in anesthesiology research. Anesthesiology 113(4):779–781PubMedCrossRef

Ahn S, Park SH, Lee KH (2013) How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research. Radiology 267(2):328–338PubMedCrossRef

Messori A, Fadda V, Gatto R, Maratea D, Trippoli S (2014) Differentiating between “no proof of difference” and “proof of no difference” for new oral anticoagulants. BMJ 348:g1955. doi:10.1136/bmj.g1955 PubMedCrossRef

Walker E, Nowacki AS (2011) Understanding equivalence and noninferiority testing. J Gen Intern Med 26(2):192–196PubMedCentralPubMedCrossRef

Migliore A, Broccoli S, Massafra U, Cassol M, Frediani B (2013) Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis. Eur Rev Med Pharmacol Sci 17(5):658–667PubMed

Tadrous M, Wong L, Mamdani MM, Juurlink DN, Krahn MD, Lévesque LE, Cadarette SM (2014) Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis. Osteoporos Int 25(4):1225–1235PubMedCrossRef

Messori A, Fadda V, Maratea D, Trippoli S, Marinai C (2014) Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods. J Endocrinol Invest 37(8):769–773

Fadda V (2014) Gastrointestinal adverse events of bisphosphonates. PubMedCommons. http://www.ncbi.nlm.nih.gov/pubmed/24287510#cm24287510_5074. Accessed 2 Jul 2014

Lumley T (2002) Network meta-analysis for indirect treatment comparisons. Stat Med 21(16):2313–2324PubMedCrossRef

10.

Hoaglin DC, Hawkins N, Jansen JP et al (2011) Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices—part 2. Value Health 14:429–437PubMedCrossRef

11.

Sobieraj DM, Cappelleri JC, Baker WL, Phung OJ, White CM, Coleman CI (2013) Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open 3(7). doi: 10.1136/bmjopen-2013-003111

12.

Greco T, Landoni G, Biondi-Zoccai G, D’Ascenzo F, Zangrillo A (2013) A Bayesian network meta-analysis for binary outcome: how to do it. Stat Methods Med Res [Epub ahead of print]

13.

Messori A (2014) Bayesian models implemented under Winbugs: can they be considered the new standard for conducting a network meta-analysis? PubMed Commons. http://www.ncbi.nlm.nih.gov/pubmed/23970014#cm23970014_6256. Accessed 15 Sep 2014

14.

NICE Clinical Guidelines, No. 92 (2010) National clinical guideline centre—acute and chronic conditions (UK). London Royal College of Physicians (UK). http://www.ncbi.nlm.nih.gov/books/NBK116530/. Accessed 14 Aug 2014

15.

Bucher HC, Guyatt GH, Griffith LE, Walter SD (1997) The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 50(6):683–691PubMedCrossRef

16.

Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA (2014) Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med 189(3):250–255PubMedCrossRef

17.

Norman G, Monteiro S, Salama S (2012) Sample size calculations: should the emperor’s clothes be off the peg or made to measure? BMJ 23(345):e5278. doi:10.1136/bmj.e5278 CrossRef

18.

Tanaka S, Kinjo Y, Kataoka Y, Yoshimura K, Teramukai S (2012) Statistical issues and recommendations for noninferiority trials in oncology: a systematic review. Clin Cancer Res 18(7):1837–1847PubMedCrossRef

19.

Yanik B, Bavbek N, Yanik T, Inegöl I, Kanbay M, Turgut FH, Uz E, Akçay A (2007) The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. Ren Fail 29(4):471–476PubMedCrossRef

20.

Miller PD, Jamal SA, Evenepoel P, Eastell R, Boonen S (2013) Renal safety in patients treated with bisphosphonates for osteoporosis: a review. J Bone Miner Res 28(10):2049–2059. doi:10.1002/jbmr.2058 PubMedCrossRef

Titel: Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference
verfasst von: V. Fadda
D. Maratea
S. Trippoli
A. Messori
Publikationsdatum: 01.02.2015
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 2/2015
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-014-0211-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves’ orbitopathy

Thanks to Reviewers 2014

Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients

The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults

Effect of hydrocortisone replacement therapy on body mass index after pituitary surgery

A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances